Ethan Miller

1.5k total citations
41 papers, 696 citations indexed

About

Ethan Miller is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Ethan Miller has authored 41 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 19 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Ethan Miller's work include Liver Disease Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Hepatitis C virus research (9 papers). Ethan Miller is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Hepatitis C virus research (9 papers). Ethan Miller collaborates with scholars based in United States, United Arab Emirates and Germany. Ethan Miller's co-authors include Rachel Wong, Karen L. Myhr, Wai T. Wong, Hamzah Abu‐Sbeih, Boris Blechacz, Naga Chalasani, Gottumukkala S. Raju, Selvi Thirumurthi, Phillip Lum and Robert S. Bresalier and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Ethan Miller

36 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ethan Miller United States 12 335 262 177 129 112 41 696
John C. McVey United States 12 98 0.3× 153 0.6× 151 0.9× 124 1.0× 61 0.5× 27 460
Masahiro Shimokawa Japan 11 102 0.3× 97 0.4× 115 0.6× 158 1.2× 97 0.9× 25 454
Caroline Clark United Kingdom 14 256 0.8× 60 0.2× 50 0.3× 188 1.5× 206 1.8× 30 668
K Kusaka Japan 8 151 0.5× 336 1.3× 572 3.2× 116 0.9× 123 1.1× 21 886
Yanjun Shi China 12 47 0.1× 104 0.4× 147 0.8× 161 1.2× 70 0.6× 26 507
Chien‐Hsueh Tung Taiwan 15 69 0.2× 144 0.5× 80 0.5× 157 1.2× 31 0.3× 42 632
Munveer S. Bhangoo United States 12 162 0.5× 105 0.4× 49 0.3× 195 1.5× 164 1.5× 27 563
Yasuaki Okuda Japan 13 70 0.2× 71 0.3× 33 0.2× 321 2.5× 44 0.4× 26 572
Doiniţa Crişan Romania 12 84 0.3× 113 0.4× 49 0.3× 96 0.7× 78 0.7× 51 398

Countries citing papers authored by Ethan Miller

Since Specialization
Citations

This map shows the geographic impact of Ethan Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Miller more than expected).

Fields of papers citing papers by Ethan Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Miller. The network helps show where Ethan Miller may publish in the future.

Co-authorship network of co-authors of Ethan Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan Miller. A scholar is included among the top collaborators of Ethan Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan Miller. Ethan Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Vinod, Zachary A. Yochum, Eric H.‐B. Huang, et al.. (2024). TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer. Oncogene. 43(19). 1431–1444. 5 indexed citations
2.
Zhang, Hao Chi, Ethan Miller, & Lan Wang. (2024). S4601 A Case of Successful Treatment of High-Grade Immune-Mediated Hepatobiliary Toxicity With Oral Budesonide: Shifting the Paradigm Away From Systemic Steroids. The American Journal of Gastroenterology. 119(10S). S2919–S2920.
3.
4.
Yılmaz, Bülent, Blessie Elizabeth Nelson, Harrys A. Torres, et al.. (2023). Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience. The Oncologist. 28(8). 714–721. 8 indexed citations
5.
6.
Zhang, Hao Chi, et al.. (2021). 655 MODERATE DOSE STEROID TREATMENT FOR IMMUNE CHECKPOINT INHIBITOR-MEDIATED HEPATOTOXICITY. Gastroenterology. 160(6). S–790. 1 indexed citations
7.
Zhang, Hao Chi, Melissa W. Taggart, Ethan Miller, et al.. (2021). S2724 Clinical Presentation, Treatment Strategies, and Chronic Sequelae of Immune Checkpoint Inhibitor-Mediated Cholangiopathy: A Case Study. The American Journal of Gastroenterology. 116(1). S1140–S1140.
8.
Zhang, Hao Chi, et al.. (2021). Hepatobiliary and Pancreatic Adverse Events. Advances in experimental medicine and biology. 1342. 339–355. 8 indexed citations
9.
Torres, Harrys A., Anna S. Lok, María E. Suarez‐Almazor, et al.. (2020). Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Supportive Care in Cancer. 29(1). 97–105. 1 indexed citations
10.
Hill, Ashley E., Ahmed Elakkad, J. Kuban, et al.. (2020). Durability of partial splenic artery embolization on platelet counts for cancer patients with hypersplenism-related thrombocytopenia. Abdominal Radiology. 45(9). 2886–2894. 7 indexed citations
11.
Phipps, Meaghan, Alexandra E. Livanos, Lara Dakhoul, et al.. (2020). Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States. The American Journal of Gastroenterology. 115(9). 1486–1495. 28 indexed citations
12.
Deng, Yang, Huakang Tu, Ethan Miller, et al.. (2018). Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. European Journal of Cancer. 92. 20–32. 23 indexed citations
13.
Wang, Yinghong, Hamzah Abu‐Sbeih, Emily Mao, et al.. (2018). Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis. Inflammatory Bowel Diseases. 24(8). 1695–1705. 178 indexed citations
14.
Raju, Gottumukkala S., Phillip Lum, William A. Ross, et al.. (2016). Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointestinal Endoscopy. 84(2). 315–325. 50 indexed citations
15.
Torres, Harrys A., Parag Mahale, Boris Blechacz, et al.. (2015). Effect of Hepatitis C Virus Infection in Patients With Cancer: Addressing a Neglected Population. Journal of the National Comprehensive Cancer Network. 13(1). 41–50. 19 indexed citations
16.
Torres, Harrys A., Ahmed O. Kaseb, Parag Mahale, Ethan Miller, & Catherine Frenette. (2014). Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series. SHILAP Revista de lepidopterología. 1. 109–109. 3 indexed citations
17.
Islam, Sameer, et al.. (2013). The Use of DNA Fingerprinting to Resolve Conflicting Results in Patients With Suspected Gastrointestinal Malignancy. Journal of Clinical Gastroenterology. 47(3). 239–241. 1 indexed citations
18.
Torres, Harrys A., Parag Mahale, Ethan Miller, et al.. (2013). Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World Journal of Hepatology. 5(6). 332–332. 2 indexed citations
19.
Decker, G. Anton, et al.. (2010). Deep enteroscopy in patients with left ventricular assist devices: practical and technical considerations. Endoscopy. 42(S 02). E194–E194. 9 indexed citations
20.
Miller, Ethan, D. Eric Steidley, Francisco A. Arabía, & G. Anton Decker. (2009). Gastric erosion associated with left ventricular assist device: new technology, new complication. Gastrointestinal Endoscopy. 70(1). 181–183. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John C. McVey Breakdown of academic impact, for papers by Masahiro Shimokawa Breakdown of academic impact, for papers by Caroline Clark Breakdown of academic impact, for papers by K Kusaka Breakdown of academic impact, for papers by Yanjun Shi Breakdown of academic impact, for papers by Chien‐Hsueh Tung Breakdown of academic impact, for papers by Munveer S. Bhangoo Breakdown of academic impact, for papers by Yasuaki Okuda Breakdown of academic impact, for papers by Doiniţa Crişan
Rankless by CCL
2026